Second Opinion Laboratory IVS: Financial statements 2020
CVR: 38502697
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Second Opinion Laboratory IVS (CVR 38502697) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -114 and a net result of DKK -114 compared with DKK 199 the year before. Equity in the 2020 report amounted to DKK 351. The solvency ratio was 15.1%.
- Gross Profit
- DKK -114
- Profit/Loss
- DKK -114
- Equity
- DKK 351
- Total Assets
- DKK 2,324
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -114 | -114 | 351 | - |
| 2019 | - | 255 | 199 | 465 | - |
| 2018 | - | 229 | 179 | 210 | - |
Official annual report
How creditworthy is Second Opinion Laboratory IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Second Opinion Laboratory IVS has published its annual report for 2019. Gross profit came to DKK 255, and the net result was DKK 199.
About Second Opinion Laboratory IVS
Second Opinion Laboratory IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2017. The company has been dissolved on 20 January 2023. The company was registered under the industry Sundhedsvæsen i øvrigt i.a.n.. In 2020, the company reported a gross profit of DKK -114 and a net result of DKK -114 compared with DKK 199 the year before. Equity in the 2020 report amounted to DKK 351.